A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Public ClinicalTrials.gov record NCT07463183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-8690 in Adult Participants With Moderately to Severely Active Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothesis is that MK-8690 is superior to placebo with respect to the proportion of participants achieving clinical remission per Modified Mayo Score at Week 12.
Study identification
- NCT ID
- NCT07463183
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 23, 2026
- Primary completion
- Oct 27, 2027
- Completion
- Dec 20, 2028
- Last update posted
- Aug 30, 2026
2026 – 2028
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinnova Research ( Site 1042) | Anaheim | California | 92805 | Recruiting |
| Southern California Research Center ( Site 1044) | Coronado | California | 92118 | Recruiting |
| Peak Gastroenterology Associates ( Site 1052) | Colorado Springs | Colorado | 80907 | Recruiting |
| South Denver Gastroenterology, PC ( Site 1068) | Englewood | Colorado | 80113 | Recruiting |
| Nature Coast Clinical Research ( Site 1045) | Inverness | Florida | 34452 | Recruiting |
| Research Associates of South Florida - Miami - Southwest 8th Street ( Site 1072) | Miami | Florida | 33134 | Recruiting |
| Gastroenterology Associates of Central Georgia ( Site 1060) | Macon | Georgia | 31201 | Recruiting |
| University of Kansas Medical Center ( Site 1077) | Kansas City | Kansas | 66160 | Recruiting |
| Tulane University School of Medicine-Gastroenterology and Hepatology ( Site 1073) | New Orleans | Louisiana | 70112 | Recruiting |
| BVL Research - Kansas ( Site 1054) | Liberty | Missouri | 64068 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07463183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 30, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07463183 live on ClinicalTrials.gov.